Learn more

KEMIJSKI INST

Overview
  • Total Patents
    190
  • GoodIP Patent Rank
    36,940
  • Filing trend
    0.0%
About

KEMIJSKI INST has a total of 190 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 1981. It filed its patents most often in Slovenia, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are WINTER GERHARD, TRANSFERT PLUS SEC and 180 THERAPEUTICS LP.

Patent filings per year

Chart showing KEMIJSKI INSTs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Jerala Roman 41
#2 Bencina Mojca 24
#3 Gaberscek Miran 22
#4 Bele Marjan 20
#5 Dominko Robert 18
#6 Orel Boris 14
#7 Lebar Tina 10
#8 Bremsak Robert 10
#9 Fekonja Ota 10
#10 Prosek Mirko 9

Latest patents

Publication Filing date Title
EP3811940A1 Substituted 4,5'-bithiazoles as inhibitors of the human dna topoisomerase ii
EP3733635A1 Sustainable production of allyl alcohol: gas-phase conversion of glycerol over metals promoted aluminosilicate zeolite catalysts in a fixed-bed continuous flow reactor
EP3733654A1 One-step synthesis of glycidol from glycerol in gas-phase fixed-bed continous flow reactor over alkali metal promoted aluminosilicate zeolite catalyst
WO2020187933A1 Method for preparation of a supported noble metal-metal alloy composite, and the obtained supported noble metal-metal alloy composite
EP3699175A1 Functionalized aliphatic polyesters and process for producing the same
WO2020141106A1 Engineered externally regulated artificial transcription regulatory system based on engineered nfat
EP3782976A1 Sustainable process for producing muconic, hexenedioic and adipic acid (and their esters) from aldaric acids by heterogeneous catalysis
EP3783104A1 Coiled-coil mediated tethering of crispr-cas and exonucleases for enhanced genome editing
WO2020030613A1 Small molecule-inhibitors of 6-phosphofructo-1-kinase for reducing lactate generation by cancer cells
EP3591743A1 Silylated cellulose interfacial protective layer on a metal surface
EP3553045A1 Process and catalysts to produce methacrylic acid monomer from biomass-derived carboxylic acids
SI25614A Enzyme aggregate 4CL:Pm-STS:Pn for increasing the production of resveratrol in Escherichia coli
SI25475A Splitted superantigens and their use in immunotherapy
SI25328A Characterization of pre-folded structures of guanine-rich residues sequences
EP3315028A1 Use of inhibitors of nlp proteins as phytopharmaceuticals for plant pathogen control
SI25289A Combination of split orthogonal proteases with dimerization domains that enable the assembly
SI25290A Method for increasing the sensitivity of cells to ultrasound and mechanical stimuli, involving gas bubbles and cells, that have increased sensitivity of mechanosensors
US2017266354A1 Cell-Based Device For Local Treatment With Therapeutic Protein
EP2926904A1 Catalyst support, a methof for producing thereof, a catalyst comprising said support and the process for converting gas mixtures of methane and carbon dioxide into syngas using said catalyst
WO2013012398A2 Electrocatalytic composite(s), associated composition(s), and associated process(es)